PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
06-Aug-2020 Insmed Reports Second Quarter 2020 Financial Results and Provides Business Update Insmed Incorporated
06-Aug-2020 CIMZIA® is the First and Only Biologic Approved in Europe with the Option for a Reduced Maintenance Dose for Patients Across the Full Axial Spondyloarthritis Spectrum UCB
06-Aug-2020 Glenmark introduces higher strength (400 mg) of FabiFlu® to reduce pill burden of COVID-19 treatment Glenmark Pharmaceuticals Ltd
06-Aug-2020 Cadila Pharma launches osteoporosis biosimilar in India CADILA PHARMCEUTICALS LTD
06-Aug-2020 RHÖN-KLINIKUM AG concludes the first six months of 2020 with increased revenues - Huge contribution towards fighting COVID-19 pandemic - Strategic partnership with Asklepios RHÖN-KLINIKUM Aktiengesellschaft
06-Aug-2020 Citius Pharmaceuticals Increases Previously Announced Bought Deal Offering to $8.4 Million Citius Pharmaceuticals, Inc.
05-Aug-2020 MorphoSys Reports Second Quarter and First Half 2020 Results MorphoSys AG
05-Aug-2020 aap Implantate AG offers its shareholders a convertible bond with a total nominal value of EUR 2.6 million; attractive offer and a major step toward securing the company's continued existence aap Implantate AG
05-Aug-2020 Xlife Sciences AG: Xlife Sciences takes stake in palleos healthcare Xlife Sciences AG
05-Aug-2020 Medios AG: Dynamic sales growth in the first half of 2020, special effects burden earnings Medios AG
05-Aug-2020 Medios AG adjusts forecast for 2020 financial year downward Medios AG
05-Aug-2020 EVOTEC AND SECARNA PHARMACEUTICALS FORM STRATEGIC PARTNERSHIP IN THE FIELD OF ANTISENSE THERAPY Evotec SE
05-Aug-2020 Secarna Pharmaceuticals and Evotec form strategic partnership in the field of antisense therapy Secarna Pharmaceuticals GmbH & Co. KG
05-Aug-2020 Immunic, Inc. Announces Pricing of $90.0 Million Public Offering of Common Stock Immunic, Inc.
04-Aug-2020 OTC Markets Group Welcomes Medexus Pharmaceuticals Inc. to OTCQX OTC Markets Group Inc.
04-Aug-2020 PharmaForce International: MSL Engagement Tactics for Leading US Pharmaceutical Companies Continue to Change Dramatically PharmaForce International
04-Aug-2020 The contract manufacturing market for live biotherapeutics and microbiome products is estimated to be worth USD 300 million by 2030, growing at a CAGR of 46%, claims Roots Analysis Roots Analysis
04-Aug-2020 Clinerion named a Finalist in the Fierce Innovation Awards – Life Sciences Edition 2020 Clinerion Ltd
04-Aug-2020 Oncopeptides starts the phase 2 PORT study comparing peripheral versus central administration of melflufen and dexamethasone in multiple myeloma Oncopeptides AB
04-Aug-2020 Pre-filled Syringes San Francisco will now take place as a Virtual Conference SMi Group Ltd